Publicly Available Information on Insurance Coverage for Maternal-Fetal Surgery
Importance: Maternal-fetal surgery has expanded rapidly in the US, but how insurance coverage supports delivery of this specialized, high-cost care has not been systematically characterized. Objective: To characterize publicly ascertainable information about how Medicaid programs and large commercial insurers cover procedures used in maternal-fetal surgery. Design, Setting, and Participants: This cross-sectional descriptive study analyzed insurance coverage policies in the US from March through August 2025. Medicaid programs and large commercial insurers were selected based on national market share. Exposure: Insurance coverage policies for maternal-fetal surgery-related procedures were assessed using publicly available fee schedules and structured outreach to payer representatives. Main Outcomes and Measures: Coverage status (covered, not covered, or data not available) for 19 maternal-fetal surgery-related Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes and 5 comparator codes. Results: The study included 50 state Medicaid programs and 30 large commercial insurers. Among Medicaid programs, coverage was high for nonspecific or individual components of procedures (eg, intrauterine transfusion: 49 of 49 available determinations [100%]) but incomplete and highly variable for codes specific to comprehensive interventions (eg, 6 of 36 available determinations [16.7%] for in utero sacrococcygeal teratoma resection). Among 44 states with available determinations for both code types, mean (SD) coverage was higher for CPT codes than S-codes (86.3% [14.1%] vs 53.0% [37.0%]; P < .001), with consistent findings in sensitivity analyses. The median (range) proportion of MFS-related codes covered per state was 14.5 (0-19) of 19 codes (76.3%). Among 5 commercial insurers with data, all 5 (100.0%) reported coverage of all 4 S-codes representing comprehensive interventions. Conclusions and Relevance: In this study, coverage of maternal-fetal surgery-related codes was incomplete and variable, and transparency in commercial coverage policies was limited. These findings suggest that coverage uncertainty may complicate health-system planning and financing for this increasingly used, high-cost care.
Authors
- Dana Zapolin
- Katie Francis (ORCID: https://orcid.org/0000-0003-1461-1147)
- Barbara Eichhorn
- Abigail B. Wilpers (ORCID: https://orcid.org/0000-0003-0625-3511)
- Amy B. Powne
- Molly A. Passarella (ORCID: https://orcid.org/0009-0000-8037-152X)
- John Abdelshaheed (ORCID: https://orcid.org/0009-0009-2161-9113)
- Bonnie Zapolin
- Isha Suba
- Jasmine Mohanlall
Institutions
- Florida State University (US)
- Boston College (US)
- University of Central Florida (US)
- Boston Children's Hospital (US)
- Cardinal Glennon Children’s Medical Center (US)
- Children's Hospital of Philadelphia (US)
- University of Pittsburgh (US)
- Magee-Womens Hospital (US)
- University of California Davis Medical Center (US)
- UC Davis Health (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.42991
- Primary Topic
- Healthcare Policy and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00